PharmaEngine Cash Flow-to-Debt Ratio
PharmaEngine cash flow-to-debt ratio. PharmaEngine (4162) has a Cash Flow-to-Debt Ratio of 0.47x as of September 2025, meaning its operating cash flow of NT$53.01 Million could theoretically repay 0% of its total liabilities (NT$112.86 Million) in one year. Check 4162 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of PharmaEngine (2009–2024)
Cash flow-to-debt ratio of PharmaEngine from 2009 to 2024. Historical debt coverage capacity for PharmaEngine across 16 annual periods. Check cash flow reinvestment rate of PharmaEngine to assess the company's total reinvestment commitment from operating cash flow.
PharmaEngine Cash Flow-to-Debt Ratio by Year (2009–2024)
PharmaEngine cash flow-to-debt ratio by year from 2009 to 2024. Year-by-year debt coverage analysis for PharmaEngine. For the full cash flow conversion analysis, see cash flow conversion of PharmaEngine.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 1.02x | NT$456.73 Million | NT$448.01 Million | ▼ -63.9% |
| 2023 | 2.82x | NT$256.97 Million | NT$91.01 Million | ▲ +32.0% |
| 2022 | 2.14x | NT$202.01 Million | NT$94.47 Million | ▼ -79.8% |
| 2021 | 10.60x | NT$929.67 Million | NT$87.70 Million | ▲ +3104.1% |
| 2020 | 0.33x | NT$64.77 Million | NT$195.78 Million | ▲ +230.0% |
| 2019 | 0.10x | NT$16.08 Million | NT$160.40 Million | ▼ -97.9% |
| 2018 | 4.88x | NT$745.23 Million | NT$152.67 Million | ▲ +387.6% |
| 2017 | -1.70x | NT$-339.30 Million | NT$199.90 Million | ▼ -131.3% |
| 2016 | 5.42x | NT$870.38 Million | NT$160.48 Million | ▼ -3.9% |
| 2015 | 5.64x | NT$447.99 Million | NT$79.41 Million | ▼ -22.5% |
| 2014 | 7.28x | NT$131.09 Million | NT$18.02 Million | ▲ +497.9% |
| 2013 | -1.83x | NT$-47.37 Million | NT$25.90 Million | ▼ -137.8% |
| 2012 | 4.83x | NT$68.64 Million | NT$14.20 Million | ▼ -72.6% |
| 2011 | 17.67x | NT$275.49 Million | NT$15.59 Million | ▲ +527.3% |
| 2010 | -4.14x | NT$-57.26 Million | NT$13.85 Million | ▼ -39.3% |
| 2009 | -2.97x | NT$-90.54 Million | NT$30.50 Million | — |